Intergen Genetik is a health care startup based in Turkey, and it was founded in 1999. The company focuses on genetic testing for nearly 5000 rare disorders through its professional laboratory. Intergen offers a wide range of services including genetics and rare diseases testing, molecular biology, pre-implantation genetic diagnosis, NIPT, whole exome sequencing, whole genome sequencing, NGS sequencing, Sanger sequencing, bioinformatics, cell and tissue cultures, cytogenetics, and pathology.
With its comprehensive range of testing services, Intergen serves a vital role in the healthcare industry, particularly in the field of genetic disorders. The company's dedication to providing advanced genetic testing solutions positions it as a significant player in the industry.
Although details about Intergen's last investment and investors are not available, the company's strong presence in the field of genetic testing and its continued operation since 1999 demonstrate its stability and ongoing relevance in the health care sector.
There is no investment information
No recent news or press coverage available for INTERGEN Genetics and Rare Diseases Diagnosis Research & Application Center.